Fen Zhu

Fen Zhu

University of Wisconsin-Madison

H-index: 10

North America-United States

About Fen Zhu

Fen Zhu, With an exceptional h-index of 10 and a recent h-index of 9 (since 2020), a distinguished researcher at University of Wisconsin-Madison, specializes in the field of Cancer biology, Hematology, Immunology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Targeting DNMT3A-mediated oxidative phosphorylation to overcome ibrutinib resistance in mantle cell lymphoma

Hypomethylating agent decitabine sensitizes diffuse large B-cell lymphoma to venetoclax

Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies

Inhibition of PRMT5 Increases Sensitivity to BH3 Mimetics in Aggressive B Cell Malignancies

Decitabine sensitizes diffuse large B cell lymphoma cells to venetoclax

Targeting BCL2 family protein phosphorylation in venetoclax resistant lymphoid malignancies

Dissecting Richter's syndrome in a multiplexed CRISPR-based mouse model reveals key changes in MYC, interferon and BCR signaling underlying transformation

EGR1 addiction in diffuse large B-cell lymphoma

Fen Zhu Information

University

Position

___

Citations(all)

423

Citations(since 2020)

375

Cited By

172

hIndex(all)

10

hIndex(since 2020)

9

i10Index(all)

10

i10Index(since 2020)

9

Email

University Profile Page

Google Scholar

Fen Zhu Skills & Research Interests

Cancer biology

Hematology

Immunology

Top articles of Fen Zhu

Targeting DNMT3A-mediated oxidative phosphorylation to overcome ibrutinib resistance in mantle cell lymphoma

Cell Reports Medicine

2024/4/16

Hypomethylating agent decitabine sensitizes diffuse large B-cell lymphoma to venetoclax

Haematologica

2023

Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies

The Journal of clinical investigation

2023/11/15

Inhibition of PRMT5 Increases Sensitivity to BH3 Mimetics in Aggressive B Cell Malignancies

Blood

2022/11/15

Fen Zhu
Fen Zhu

H-Index: 7

Decitabine sensitizes diffuse large B cell lymphoma cells to venetoclax

Cancer Research

2022/6/15

Fen Zhu
Fen Zhu

H-Index: 7

Targeting BCL2 family protein phosphorylation in venetoclax resistant lymphoid malignancies

Cancer Research

2022/6/15

Fen Zhu
Fen Zhu

H-Index: 7

Dissecting Richter's syndrome in a multiplexed CRISPR-based mouse model reveals key changes in MYC, interferon and BCR signaling underlying transformation

Blood

2021/11/23

EGR1 addiction in diffuse large B-cell lymphoma

Molecular Cancer Research

2021/8/1

Loss-of-function of Fbxo10, encoding a post-translational regulator of BCL2 in lymphomas, has no discernible effect on BCL2 or B lymphocyte accumulation in mice

Plos one

2021/4/29

Fen Zhu
Fen Zhu

H-Index: 7

Lixin Rui
Lixin Rui

H-Index: 15

CXCR4 allows T cell acute lymphoblastic leukemia to escape from JAK1/2 and BCL2 inhibition through CNS infiltration

Leukemia & lymphoma

2021/4/16

Fen Zhu
Fen Zhu

H-Index: 7

Lixin Rui
Lixin Rui

H-Index: 15

See List of Professors in Fen Zhu University(University of Wisconsin-Madison)